New study aims to catch lung cancer earlier in uninsured smokers
NCT ID NCT03181256
First seen Nov 01, 2025 · Last updated Jun 21, 2026 · Updated 34 times
Summary
This study follows 45 current or former smokers who are uninsured and have a heavy smoking history. Researchers collect samples like sputum, blood, and urine, along with CT scans, to look for early signs of lung cancer. The goal is to find better ways to detect lung cancer early in people who often lack access to regular screening.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help develop better ways to catch lung cancer early in high-risk, uninsured smokers.
What could go wrong
This is a small, early-stage study focused on collecting data, not testing a treatment. The biomarkers may not prove reliable for widespread use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.